Please use this identifier to cite or link to this item:
Title: Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain.
Issue Date: Sep-2017
Citation: Br J Clin Pharmacol.2017 Sep;(83)9:1921-1931
Abstract: Pragmatic randomized clinical trials (pRCTs) collect data that have the potential to improve medical care significantly. However, these trials may be undermined by the requirement to obtain written informed consent, which can decrease accrual and increase selection bias. Recent data suggest that the majority of the US public endorses written consent for low-risk pRCTs. The present study was designed to assess whether this view is specific to the US.
PMID: 28419518
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5582372.pdf519.12 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.